Cancel
Kin-Hung Peony Yu
Chief Medical Officer
@
Apollomics
wz1d058t.d9qqj.5z@03vqb161dj8jj.wjw
Sign up to see email
Known information
- Joined Apollomics in 2021
- Has over 25 years of experience in pharmaceutical leadership, patient care, and drug development
- Expertise in clinical regulatory strategy and execution of clinical programs of innovative biopharmaceuticals
- Previously worked for FibroGen, Inc. as a vice president
- Served as the vice president and head of clinical research at Anesiva, Inc.
- Was a director of clinical development at ALZA Corporation, a subsidiary of Johnson & Johnson
- Held roles of increasing responsibility in clinical development at Pain Therapeutics, Inc. and at Elan Corporation plc
- Obtained an M.D. degree from the University of California, Davis School of Medicine
- Completed residency training at Stanford University School of Medicine
- Authored or co-authored 12 peer-reviewed publications
- Holds a medical license registered in California
- Is an independent nonexecutive director at STAAR Surgical Company
About Apollomics
Apollomics is a biopharmaceutical company focused on developing innovative oncology therapies, including targeted treatments and immune system enhancers, with operations in the U.S., China, and Australia.
Report inaccurate information
